Forty years of β-lactam research

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 6, 1998, Pages 589-603

  Rolinson, George N ^a,b  

^a Parkgate House   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 AMINOPENICILLANIC ACID; AMOXICILLIN; AMPICILLIN; BETA LACTAM ANTIBIOTIC; CARBENICILLIN; CLOXACILLIN; FLUCLOXACILLIN; METICILLIN; PENICILLIN DERIVATIVE; TICARCILLIN;

ANTIBIOTIC THERAPY; CYTOLOGY; REVIEW;

ANIMALS; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; HISTORY, 20TH CENTURY; HUMANS; METHICILLIN RESISTANCE; PENICILLINS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS;

EID: 0031865125     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.6.589     Document Type: Review

References (96)

1. Fleming, A. (1929). On the antibacterial action of cultures of Penicillium, with special reference to their use in the isolation of B.influenzae. British Journal of Experimental Pathology 10, 226-36.
2. Chain, E., Florey, H. W., Gardner, A. D., Heatley, N. G., Jennings, M. A., Orr-Ewing, J. et al. (1940). Penicillin as a chemotherapeutic agent. Lancet ii, 226-8.
3. Rolinson, G. N. (1952). Respiration of Penicillium chrysogenum in penicillin fermentations. Journal of General Microbiology 6, 336-43.
4. Rolinson, G. N. & Lumb, M. (1953). The effect of aeration on the utilization of respiratory substrates by Penicillium chrysogenum in submerged culture. Journal of General Microbiology 8, 265-72.
5. Rolinson, G. N. (1954). The effect of certain enzyme inhibitors on respiration and on penicillin formation by Penicillium chrysogenum. Journal of General Microbiology 11, 412-9.
6. Soltero, F. V. & Johnson, M. J. (1953). Effect of the carbohydrate nutrition of penicillin production by Penicillium chrysogenum Q-176. Applied Microbiology 1, 52-7.
7. Brewer, G. A. & Johnson, M. J. (1953). Activity and properties of para-aminobenzyl penicillin. Applied Microbiology 1, 163-6.
8. Batchelor, F. R., Doyle, F. P., Nayler, J. H. & Rolinson, G. N. (1959). Synthesis of penicillin: 6-aminopenicillanic acid in penicillin fermentations. Nature 183, 257-8.
9. Abraham, E. P. & Newton, G. G. F. (1961). The structure of cephalosporin C. Biochemical Journal 79, 377-93.
10. Morin, R. B., Jackson, B. G., Flynn, E. H. & Roeske, R. W. (1962). Chemistry of cephalosporin antibiotics. 1. 7-Aminocephalosporanic acid. Journal of the American Chemical Society 84, 3400-1.
11. Rolinson, G. N., Batchelor, F. R., Butterworth, D., Cameron-Wood, J., Cole, M., Eustace, G. C. et al. (1960). Formation of 6-aminopenicillanic acid from penicillin by enzymatic hydrolysis. Nature 187, 236-7.
12. Kaufmann, W. & Bauer, K. (1960). Enymatische spaltung und resynthese von Penicillin. Naturwissenschaften 47, 474-5.
13. Claridge, C. A., Gourevitch, A. & Lein, J. (1960). Bacterial penicillin amidase. Nature 187, 237-8.
14. Huang, H. T., English, A. R., Seto, T. A., Shull, G. M. & Sobin, B. A. (1960). Enzymatic hydrolysis of the side chain of penicillins. Journal of the American Chemical Society 82, 3790-1.
15. Rolinson, G. N. & Sutherland, R. (1973). Semi-synthetic penicillins. Advances in Pharmacology and Chemotherapy 11, 151-220.
16. Rolinson, G. N. (1986). β-Lactam antibiotics. Journal of Antimicrobial Chemotherapy 17, 5-36.
17. Rolinson, G. N., Stevens, S., Batchelor, F. R., Cameron-Wood, J. C. & Chain, E. B. (1960). Bacteriological studies on a new penicillin - BRL 1241. Lancet ii, 564-7.
18. Jevons, M. P. (1961). 'Celbenin'-resistant staphylococci. British Medical Journal i, 124-5.
19. Rolinson, G. N. (1961). 'Celbenin'-resistant staphylococci. British Medical Journal i, 125-6.
20. Sutherland, R. & Rolinson, G. N. (1964). Characteristics of methicillin-resistant staphylococci. Journal of Bacteriology 87, 887-99.
21. Brown, D. F. & Reynolds, P. E. (1980). Intrinsic resistance to β-lactam antibiotics in Staphylococcus aureus. FEBS Letters 122, 275-8.
22. Hartman, B. J. & Tomasz, A. (1981). Altered penicillin binding proteins in methicillin-resistant strains of Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 19, 726-35.
23. Batchelor, F. R., Cameron-Wood, J., Chain, E. B. & Rolinson, G. N. (1963). Studies on penicillanase produced by a strain of Staphylococcus aureus. Proceedings of the Royal Society of London, Series B 158, 311-28.
24. Rolinson, G. N. & Stevens, S. (1961). Microbiological studies on a new broad spectrum penicillin 'Penbritin'. British Medical Journal ii, 191-6.
25. Sutherland, R. & Rolinson, G. N. (1964). Activity of ampicillin in vitro compared with other antibiotics. Journal of Clinical Pathology 17, 461-5.
26. Ayliffe, G. A. (1963). Ampicillin inactivation and sensitivity of coliform bacilli. Journal of General Microbiology 30, 339-48.
27. Percival, A., Brumfitt, W. & de Louvois, J. (1963). The role of penicillanase in determining natural and acquired resistance of Gram-negative bacteria to penicillin. Journal of General Microbiology 32, 77-89.
28. Smith, J. T. & Hamilton-Miller, J. M. T. (1963). Differences between penicillanases from Gram-positive and Gram-negative bacteria. Nature 197, 976-8.
29. Barber, M. & Garrod, L. P. (1963). Antibiotics and Chemotherapy, p. 340. Churchill Livingstone, Edinburgh.
30. Bond, J. M., Lightbown, J. W., Barber, M. & Waterworth, P. M. (1963). A comparison of four phenoxypenicillins. British Medical Journal ii, 956-61.
31. Klein, J. O & Finland, M. (1963). The new penicillins. New England Journal of Medicine 268, 1074-82.
32. Geraci, J. E., Hoffmeister, R. T., Nichols, D. R. & Needham, G. M. (1962). Preliminary clinical and laboratory experiences with a new oral penicillin: 5-methyl-3-phenyl-4-isoxazolyl penicillin. Proceedings of Staff Meetings, Mayo Clinic 37, 137-50.
33. Kirby, W. M. M., Rosenfeld, L. S. & Brodie, J. (1962). Oxacillin: laboratory and clinical investigation. Journal of the American Medical Association 181, 739-44.
34. Rolinson, G. N. (1964). The significance of protein binding of penicillins. In Therapy with the New Penicillins, Proceedings of the International Conference held at the Apothecaries Hall, London (Brumfitt, W. & Williams, J. D., Eds), pp. 20-2. Postgraduate Medicine, London.
35. Rolinson, G. N. (1967). The significance of protein binding of antibiotics in vitro and in vivo. In Recent Advances in Medical Microbiology (Waterson, A. P., Ed.), pp. 254-83. J. & A. Churchill, London.
36. Kunin, C. M. (1965). Effect of serum binding on the distribution of penicillins in the rabbit. Journal of Laboratory and Clinical Medicine 65, 406-15.
37. Craig, W. A. & Kunin, C. M. (1976). Significance of serum protein and tissue binding of antimicrobial agents. Annual Review of Medicine 27, 287-300.
38. Peterson, L. R. & Gerding, D. N. (1978). Prediction of cefazolin penetration into high-and low-protein-containing extravascular fluid: new method for performing simultaneous studies. Antimicrobial Agents and Chemotherapy 14, 533-8.
39. Rolinson, G. N. (1980). The significance of protein binding of antibiotics in antibacterial chemotherapy. Journal of Antimicrobial Chemotherapy 6, 311-7.
40. Merrikin, D. J., Briant, J. & Rolinson, G. N. (1983). Effect of protein binding on antibiotic activity in vivo. Journal of Antimicrobial Chemotherapy 11, 233-8.
41. Rolinson, G. N. & Sutherland, R. (1965). The binding of antibiotics to serum proteins. British Journal of Pharmacology and Chemotherapy 25, 638-50.
42. Sutherland, R., Croydon, E. A. P. & Rolinson, G. N. (1972). Amoxycillin: a new semi-synthetic penicillin. British Medical Journal iii, 13-6.
43. Rolinson, G. N. (1974). Laboratory evaluation of amoxycillin. Journal of Infectious Diseases 129, Suppl., S139-45.
44. Knudsen, E. T., Rolinson, G. N. & Stevens, S. (1961). Absorption and excretion of 'Penbritin'. British Medical Journal ii, 198-200.
45. Sutherland, R., Croydon, E. A. P. & Rolinson, G. N. (1970). Flucloxacillin, a new isoxazolyl penicillin compared with oxacillin, cloxacillin and dicloxacillin. British Medical Journal iv, 455-60.
46. Rolinson, G. N. & Sutherland, R. (1967). Carbenicillin, a new semi-synthetic penicillin active against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 7, 609-13.
47. Brumfitt, W., Percival, A & Leigh, D. A. (1967). Clinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. Lancet i, 1289-93.
48. Jones, R. J. & Lowbury, E. J. (1967). Prophylaxis and therapy for Pseudomonas aeruginosa infection with carbenicillin and with gentamicin. British Medical Journal iii, 79-82.
49. Sutherland, R., Burnett, J. & Rolinson, G. N. (1970). α-Carboxy-3-thienylmethylpenicillin (BRL2288) a new semi-synthetic penicillin: in vitro evaluation. Antimicrobial Agents and Chemotherapy 10, 390-5.
50. Knudsen, E. T., Rolinson, G. N. & Sutherland, R. (1967). Carbenicillin: a new semi-synthetic penicillin active against Pseudomonas pyocyanea. British Medical Journal iii, 75-8.
51. Gwynn, M. N., Webb, L. T. & Rolinson, G. N. (1981). Regrowth of Pseudomonas aeruginosa and other bacteria after the bactericidal action of carbenicillin and other β-lactam antibiotics. Journal of Infectious Diseases 144, 263-9.
52. Duguid, J. P. (1951). The demonstration of bacterial capsules and slime. Journal of Pathology and Bacteriology 63, 673-85.
53. Acred, P., Hunter, P. A., Mizen, L. & Rolinson, G. N. (1970). α-Amino-p-hydroxybenzylpenicillin (BRL 2333), a new broad-spectrum semi-synthetic penicillin: in vivo evaluation. Antimicrobial Agents and Chemotherapy 10, 416-22.
54. Hunter, P. A., Rolinson, G. N. & Witting, D. A. (1973). Comparative activity of amoxycillin and ampicillin in an experimental bacterial infection in mice. Antimicrobial Agents and Chemotherapy 4, 285-93.
55. Selbie, F. R. & O'Grady, F. (1954). A measurable tuberculosis lesion in the thigh of the mouse. British Journal of Experimental Pathology 35, 556-65.
56. Rolinson, G. N., Macdonald, A. C. & Wilson, D. A. (1977). Bactericidal action of β-lactam antibiotics on Escherichia coli with particular reference to ampicillin and amoxycillin. Journal of Antimicrobial Chemotherapy 3, 541-53.
57. Hunter, P. A., Rolinson, G. N. & Witting, D. A. (1975). Effect of carbenicillin on Pseudomonas infection. In Chemotherapy, Vol. 2 (Williams, J. D. & Geddes, A. M., Eds), pp. 289-93. Plenum, New York.
58. Parker, R. F. & Marsh, H. C. (1946). The action of penicillin on staphylococcus. Journal of Bacteriology 51, 181-6.
59. Eagle, H. & Musselman, A. D. (1949). The slow recovery of bacteria from the toxic effects of penicillin. Journal of Bacteriology 58, 475-90.
60. Wilson, D. A. & Rolinson, G. N. (1979). The recovery period following exposure of bacteria to penicillins. Chemotherapy 25, 14-22.
61. Rolinson, G. N. (1973). Plasma concentrations of penicillin in relation to the antibacterial effect. In Biological Effects of Drugs in Relation to their Plasma Concentrations (Davies, D. S. & Pritchard, B. N. C., Eds), pp. 183-9. Macmillan, London.
62. Bodey, G. P. & Pan, T. (1976). Effect of cephalothin on growth patterns of micro-organisms. Japanese Journal of Antibiotics 29, 1092-5.
63. Lorian, V. & Atkinson, B. (1976). Effects of subinhibitory concentrations of antibiotics on cross walls of cocci. Antimicrobial Agents and Chemotherapy 9, 1043-55.
64. Gardner, A. D. (1940). Morphological effects of penicillin on bacteria. Nature 146, 837-8.
65. Starka, J. & Moravova, J. (1967). Cellular division of penicillin-induced filaments of Escherichia coli. Folia Microbiologica 12, 240-7.
66. Rolinson, G. N. (1980). Effect of β-lactam antibiotics on bacterial cell growth rate. Journal of General Microbiology 120, 317-23.
67. Abraham, E. P. (1949). The action of antibiotics on bacteria. In Antibiotics, pp. 1438-96. Oxford University Press, Oxford.
68. Lorian, V. (1975). Some effects of subinhibitory concentrations of penicillin on the structure and division of staphylococci. Antimicrobial Agents and Chemotherapy 7, 864-70.
69. Greenwood, D. (1976). Differentiation of mechanisms responsible for inoculum effects in the response of Escherichia coli to a variety of antibiotics. Journal of Antimicrobial Chemotherapy 2, 87-95.
70. Shah, P. M., Heetderks, G. & Stille, W. (1976). Activity of amikacin at sub-inhibitory levels. Journal of Antimicrobial Chemotherapy 2, 97-100.
71. Merrikin, D. & Rolinson, G. N. (1979). Antibiotic levels in experimentally infected mice in relation to therapeutic effect and antibacterial activity in vitro. Journal of Antimicrobial Chemotherapy 5, 423-9.
72. Richmond, M. H. & Sykes, R. B. (1973). The β-lactamases of Gram-negative bacteria and their possible physiological role. Advances in Microbial Physiology 9, 31-85.
73. Gwynn, M. N. & Rolinson, G. N. (1980). Selection of variants of Pseudomonas aeruginosa resistant to β-lactam antibiotics. Infections 8, 73-80.
74. Gwynn, M. N. & Rolinson, G. N. (1983). Selection of variants of Gram-negative bacteria with elevated production of type 1 β-lactamase. Journal of Antimicrobial Chemotherapy 11, 577-81.
75. Gootz, T. D. & Sanders, C. C. (1983). Characterization of β-lactamase induction in Enterobacter cloacae. Antimicrobial Agents and Chemotherapy 23, 91-7.
76. Gootz, T. D., Jackson, D. B. & Sherris, J. C. (1984). Development of resistance to cephalosporins in clinical strains of Citrobacter spp. Antimicrobial Agents and Chemotherapy 25, 591-5.
77. Livermore, D. M., Williams, R. J., Lindridge, M. A., Slack, R. C. B. & Williams, J. D. (1982). Pseudomonas aeruginosa isolates with modified β-lactamase inducibility: effects on β-lactam sensitivity. Lancet i, 1466-7.
78. Shannon, K., King, A. & Phillips, I. (1982). Development of resistance to β-lactam antibiotics during therapy of Pseudomonas aeruginosa infections. Lancet i, 1466.
79. Preheim, L. C., Penn, R. G., Sanders, C. C., Goering, R. V. & Giger, D. K. (1982). Emergence of resistance to β-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections. Antimicrobial Agents and Chemotherapy 22, 1037-41.
80. Lampe, M. F., Allan, B. J., Minshew, B. H. & Sherris, J. C. (1982). Mutational enzymatic resistance of Enterobacter species to β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 21, 655-60.
81. Sanders, C. C., Moellering, R. C., Martin, R. R., Perkins, R. L., Strike, D. G., Gootz, T. D. et al. (1982). Resistance to cefamandole: a collaborative study of emerging clinical problems. Journal of Infectious Diseases 145, 118-25.
82. Sanders, C. C. & Sanders, W. E. (1983). Emergence of resistance during therapy with the newer β-lactam antibiotics: role of inducible β-lactamases and implications for the future. Reviews of Infectious Diseases 5, 639-48.
83. Sanders, C. C. (1983). Novel resistance selected by the new expanded-spectrum cephalosporins: a concern. Journal of Infectious Diseases 147, 585-9.
84. Rolinson, G. N. (1987). β-Lactamases: questions and controversies. In Programs and Abstracts of the Twenty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, New York, 1987. American Society for Microbiology, Washington, DC.
85. Rolinson, G. N. (1989). β-Lactamase induction and resistance to β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 23, 1-2.
86. Rolinson, G. N. (1980). The history and background of Augmentin. In Augmentin: Clavulanate-Potentiated Amoxycillin. Proceedings of the First Symposium, 1980 (Rolinson, G. N. & Watson, A., Eds), pp. 3-7. Excerpta Medica, Amsterdam.
87. Butterworth, D., Cole, M., Hanscomb, G. & Rolinson, G. N. (1979). Olivanic acids, a family of β-lactam antibiotics with β-lactamase inhibitory properties produced by Streptomyces species. 1. Detection, properties and fermentation studies. Journal of Antibiotics 32, 287-94.
88. Brown, A. G., Butterworth, D., Cole, M., Hanscomb, G., Hood, J. D., Reading, C. et al. (1976). Naturally-occurring β-lactamase inhibitors with antibacterial activity. Journal of Antibiotics 29, 668-9.
89. Rolinson, G. N. (1991). Evolution of β-lactamase inhibitors. Reviews of Infectious Diseases 13, Suppl. 9, S727-32.
90. Rolinson, G. N. (1994). A review of the microbiology of amoxycillin/clavulanic acid over the 15 year period 1978-1993. Journal of Chemotherapy 6, 283-318.
91. Coghill, R. D., Stodola, F. H. & Wachel, J. L. (1949). Chemical modifications of natural penicillins. In The Chemistry of Penicillin (Clarke, H. T., Johnson, J. R. & Robinson, R., Eds), pp. 680-7. Princeton University Press, Princeton, NJ.
92. Behrens, O. K., Corse, J., Edwards, J. P., Garrison, L., Jones, R. G., Soper, Q. F. et al. (1948). Biosynthesis of penicillins IV. New crystalline biosynthetic penicillins. Journal of Biological Chemistry 175, 793-809.
93. Perlstein, D. & Liebmann, A. J. (1945). The in vitro protection of penicillin from inactivation by penicillinase. Science 102, 174-5.
94. Reid, R. D., Felton, L. C. & Pittroff, M. A. (1946). Prolongation of penicillin activity with penicillinase-inhibiting compounds. Proceedings of the Society for Experimental Biology and Medicine 63, 438-43.
95. Eagle, H. (1949). The recovery of bacteria from the toxic effects of penicillin. Journal of Clinical Investigation 28, 832-6.
96. Eagle, H., Fleischmann, R. & Musselman, A. D. (1950). Effect of schedule of administration on the therapeutic efficacy of penicillin. Importance of the aggregate time penicillin remains at effectively bactericidal levels. American Journal of Medicine 9, 280-99.